Search research articles
Contact Us
Filters
Showing results (131-140 of 144) with videos related to
Page
of 15
Sort By:
ACS Medicinal Chemistry Letters
|
September 19, 2019
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"
Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
Cancers
|
January 1, 2020
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer
Rosaria Benedetti, Carmela Dell'Aversana, Tommaso De Marchi, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease
Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Editor's Note: RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
Vincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2018
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
Vincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 13, 2022
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency
Albino Carrizzo, Concetta Iside, Angela Nebbioso, et al.
The International Journal of Biochemistry & Cell Biology
|
July 16, 2024
Corrigendum to "Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities" [Int. J. Biochem. Cell Biol. 39(10) (2007) 1902-1914]
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
The International Journal of Biochemistry & Cell Biology
|
July 3, 2007
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
Cancers
|
November 13, 2025
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers
Maurizio Capuozzo, Carmine Picone, Francesco Sabbatino, et al.
Oncogene
|
September 13, 2025
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis
Guglielmo Bove, Mehrad Babaei, Alberto Bueno-Costa, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 144) with videos related to
Sort By:
Page
of 15
ACS Medicinal Chemistry Letters
|
September 19, 2019
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"
Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
Cancers
|
January 1, 2020
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer
Rosaria Benedetti, Carmela Dell'Aversana, Tommaso De Marchi, et al.
ACS Medicinal Chemistry Letters
|
April 19, 2019
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease
Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Editor's Note: RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
Vincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2018
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
Vincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 13, 2022
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency
Albino Carrizzo, Concetta Iside, Angela Nebbioso, et al.
The International Journal of Biochemistry & Cell Biology
|
July 16, 2024
Corrigendum to "Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities" [Int. J. Biochem. Cell Biol. 39(10) (2007) 1902-1914]
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
The International Journal of Biochemistry & Cell Biology
|
July 3, 2007
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities
Paola Bontempo, Luigi Mita, Marco Miceli, et al.
Cancers
|
November 13, 2025
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers
Maurizio Capuozzo, Carmine Picone, Francesco Sabbatino, et al.
Oncogene
|
September 13, 2025
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis
Guglielmo Bove, Mehrad Babaei, Alberto Bueno-Costa, et al.
Page
of 15